Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.91B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$469M |
| 3 |
NVIDIA
NVDA
|
+$461M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$461M |
| 5 |
Citigroup
C
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.29B |
| 2 |
Tesla
TSLA
|
+$303M |
| 3 |
Meta Platforms (Facebook)
META
|
+$264M |
| 4 |
iShares MSCI Brazil ETF
EWZ
|
+$257M |
| 5 |
Goldman Sachs
GS
|
+$247M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.28% |
| 2 | Consumer Discretionary | 0.93% |
| 3 | Financials | 0.81% |
| 4 | Communication Services | 0.69% |
| 5 | Healthcare | 0.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
126
PUT
DELISTED
Celgene Corp
CELG
| $323M | 0.13% |
5,045,500
+903,000
| +22% | +$66.7M |
|
|
127
NVIDIA
NVDA
$5.2T
| $322M | 0.13% |
96,437,200
+96,404,240
| +292,489% | +$461M |
|
128
PUT
Regeneron Pharmaceuticals
REGN
$85.9B
| $322M | 0.13% |
861,700
+35,400
| +4% | +$13M |
|
129
CALL
General Motors
GM
$77.2B
| $322M | 0.13% |
9,621,600
+3,572,100
| +59% | +$123M |
|
130
PUT
PayPal
PYPL
$52.7B
| $318M | 0.13% |
3,781,900
+70,200
| +2% | +$5.85M |
|
131
CALL
Comcast
CMCSA
$95.3B
| $316M | 0.13% |
9,289,600
+1,612,000
| +21% | +$58.9M |
|
132
PUT
Procter & Gamble
PG
$336B
| $314M | 0.12% |
3,411,800
-2,070,000
| -38% | -$185M |
|
133
CALL
Biogen
BIIB
$32B
| $313M | 0.12% |
1,039,900
-239,100
| -19% | -$76.3M |
|
134
CALL
Constellation Brands
STZ
$23.2B
| $311M | 0.12% |
1,935,300
-392,400
| -17% | -$78M |
|
135
CALL
Bristol-Myers Squibb
BMY
$137B
| $308M | 0.12% |
5,921,400
+430,100
| +8% | +$23.1M |
|
136
PUT
State Street Financial Select Sector SPDR ETF
XLF
$57.8B
| $303M | 0.12% |
12,706,700
+5,108,800
| +67% | +$133M |
|
137
CALL
Cisco
CSCO
$438B
| $300M | 0.12% |
6,930,900
-1,673,400
| -19% | -$76.6M |
|
138
CALL
IBM
IBM
$222B
| $300M | 0.12% |
2,762,068
-2,207,373
| -44% | -$265M |
|
139
Gilead Sciences
GILD
$181B
| $298M | 0.12% |
4,771,514
+525,858
| +12% | +$36.8M |
|
140
PUT
Lowe's Companies
LOW
$121B
| $298M | 0.12% |
3,226,600
+1,341,900
| +71% | +$129M |
|
141
PUT
Cigna
CI
$73.3B
| $297M | 0.12% |
1,561,200
+763,900
| +96% | +$159M |
|
142
Wells Fargo
WFC
$254B
| $296M | 0.12% |
6,424,434
-1,165,485
| -15% | -$59.7M |
|
143
PUT
AbbVie
ABBV
$468B
| $295M | 0.12% |
3,203,400
-358,100
| -10% | -$31.5M |
|
144
CALL
Intuitive Surgical
ISRG
$134B
| $292M | 0.12% |
1,827,000
-55,200
| -3% | -$9.35M |
|
145
PUT
McDonald's
MCD
$192B
| $290M | 0.12% |
1,632,200
-213,500
| -12% | -$37.9M |
|
146
PUT
Morgan Stanley
MS
$336B
| $288M | 0.11% |
7,274,100
+2,104,700
| +41% | +$91.8M |
|
147
CALL
NXP Semiconductors
NXPI
$56.9B
| $288M | 0.11% |
3,932,700
+127,500
| +3% | +$10.1M |
|
|
148
CALL
iShares MSCI EAFE ETF
EFA
$80B
| $286M | 0.11% |
4,872,300
-658,500
| -12% | -$41.1M |
|
149
PUT
State Street SPDR S&P Biotech ETF
XBI
$11.2B
| $285M | 0.11% |
3,973,500
+1,645,700
| +71% | +$133M |
|
150
Peabody Energy
BTU
$3.37B
| $285M | 0.11% |
9,335,303
+5,213,612
| +126% | +$175M |
|
Similar funds
Jeff Yass's Q4 2018 Portfolio in Review
As of Q4 2018, Jeff Yass held 10,809 positions worth $252B, down 17% from $304B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass's Q4 2018 filing shows 1,721 new, 3,152 increased, 3,864 reduced and 1,983 closed positions. Its largest new stake was iShares MSCI EAFE ETF: 7,515,967 shares worth $442M. The largest sale was Amazon, an estimated $1.29B.
By sector, the portfolio is most concentrated in Technology at 2.3% of assets, up from 1.3% a quarter earlier, followed by Consumer Discretionary and Financials.
- Jeff Yass's largest Q4 2018 buy was iShares MSCI EAFE ETF: 7,515,967 shares worth $442M.
- Jeff Yass added most to Apple in Q4 2018, an estimated $2.91B increase.
- Jeff Yass's biggest Q4 2018 reduction was Amazon, cutting an estimated $1.29B.
- Jeff Yass fully exited Tesla in Q4 2018, selling an estimated $303M.
- Jeff Yass's ten largest holdings make up 26% of its $252B portfolio in Q4 2018.
- Jeff Yass opened 1,721 new positions and closed 1,983 in Q4 2018.
- Jeff Yass's portfolio value fell 17% quarter-over-quarter to $252B.
Based on Susquehanna International Group's 13F filing for Q4 2018, filed 14 Feb 2019.